Nasal vaccine (file photo)
London: The Serum Institute of India (SII) has launched a trial of the coronavirus nasal vaccine in Britain. The SII nasal vaccine is undergoing first-stage testing. The Serum Institute of India will invest 24 24 million to expand its vaccine business in the UK and open a new sales office, which will create a huge number of employment opportunities. Denmark has banned the Johnson and Johnson Corona vaccine
The UK Prime Minister’s Office has announced it as part of a বিল 1 billion Indo-UK trade promotion partnership, which will create around 500,000 new jobs in the UK. About 20 Indian companies, including Pune-based vaccine makers, have announced significant investments in the UK in healthcare, biotech and software.
It is also learned that the Serum Institute of India (SII) has started the first phase trial in the UK for the coronavirus nasal vaccine.
The UK Prime Minister’s Office said on Monday in the context of SII’s plan, “The sales office is expected to create one billion new American businesses, including 200 200 million invested in the UK.” Gaya, ” Serum (SII)) will be invested in clinical trials, research and development and vaccine development. It will help Britain and the world defeat the coronavirus epidemic and other deadly diseases. ”
In the healthcare sector, another Indian company called Global Gene Corps will invest 59 million over the next five years.
Recently, 40-year-old SII CEO Adar Punawala told a London newspaper that he had been receiving constant threats from some chief ministers and corporate leaders. Due to which they had to leave the country.